ITTN - Israel Tech Transfer Network :: Technology Opportunities

Use of Antisense Oligonucleotides Against cPLA2 In the Treatment of Cancer

BGN - code: Patent References: US 8,242,255; 8,735,368 IL 178764 EP 1758996 (Validated: Germany, France, UK)

Researchers

Rachel Levy, Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University and Soroka Medical Center, Beer Sheva, Israel

To learn more about this technology, please contact:

Ora Horovitz

Senior VP. Business Development

Send email

BGN Technologies Ltd. – Technology Transfer Company of Ben-Gurion University, POB 653, Beer-Sheva, 84105, Israel. Tel: +972-8-6236949 Fax: +972-8-627-6420

More Technologies by:

Rachel Levy (3)

Download page as PDF